MaineMOM

MaineMOM is a MaineCare program that provides team-based care for pregnant and postpartum individuals with opioid use disorder (OUD‡). Services are available during pregnancy and through 12 months postpartum* and are designed to support recovery, promote healthy parenting, and improve maternal and infant health outcomes.

Through the MaineMOM program, participating providers deliver coordinated, trauma-informed, and compassionate car that addresses both clinical and social needs. The model emphasizes continuity of care, multidisciplinary collaboration, and long-term recovery support for pregnant and postpartum individuals. 

‡ While MaineMOM specifically serves patients with OUD, most participating MaineMOM sites also provide care for individuals with a full range of substance use disorders in addition to OUD.

* A pregnancy does not need to be carried to full term for an individual to qualify for MaineMOM services. Postpartum individuals are not required to have custody of their infants to be eligible for MaineMOM services.

MaineMOM Services

MaineCare MaineMOM services include:

• Perinatal care up to 12 months postpartum with integrated OUD treatment
• Care plan development to support individual needs of patients, and identify health-related social needs
• Transition support between inpatient, outpatient, and other care settings
• Referrals for community resources
• Substance use and perinatal care education
• Access to recovery-focused services

See the MaineMOM One-Pager (PDF) for a summary of the model.

Information about MaineMOM service locations across the state can be found at www.treatmentconnection.com.

Looking to become a MaineMOM provider?

• MaineMOM Policy: MaineCare Benefits Manual, Chapter II, Section 89
• MaineMOM Provider Application

MaineCare Provider Resources:

• MaineMOM Performance Benchmarks
• MaineCare Communications Materials
  • MaineMOM poster
  • MaineMOM flyer
  • MaineMOM rack card

Clinical Resources and Recommendations

Breastfeeding & Substance Use Disorder (SUD)

• Guidelines for the Use of Human Milk in the Context of Substance Use Disorder (PDF) (OMS, 2026)
• Breastfeeding Recommendations for People who Use Substances (AWHONN, 2023)
• Cannabis Use During Pregnancy and Lactation (ACOG, 2025)

Buprenorphine Monotherapy vs. Combination Therapy during Pregnancy

• Use of Buprenorphine Monotherapy vs. Combination Therapy During Pregnancy: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020) (PDF) 

Hepatitis C & SUD

• Hepatitis - Disease Surveillance Epidemiology Program (MECDC; DHHS Maine)
• MaineMOM Hepatitis C Treatment Guide
• Clinical Recommendations for Hepatitis C Screening in Adults (CDC, 2020)
• Clinical Recommendations for Testing, Managing, and Treating Hepatitis C in Children (AASLD & IDSA, 2020)

Infant Care

• Overview of the Eat, Sleep, Console Model of Care (NICHQ, 2019)
• Approaches to Coordinated Care for Mothers (AAP, 2020),

MaineMOM Learning Collaboration ECHO Sessions

• MaineMOM ECHO Learning Collaborative series - YouTube

Mental Health

• Treatment Guidance for SUD and Co-Occurring Disorders: SAMHSA TAP 42 (SAMHSA, 2020)
• Webinar Addressing Perinatal Mood and Anxiety Disorders (ACOG, 2019)
• Tools to Support Postpartum Mental Health (Postpartum Support International)
• FAQ on Postpartum Depression (ACOG, 2019)
• Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (ACOG, 2023)

Pain Management

• Clinical Recommendations for Managing Pain During and After Delivery (MCPAP, 2021)
• Recommended Perioperative Management of Patients Prescribed Buprenorphine for OUD: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020)

Poly- and Other Substance Use During Pregnancy

• Polysubstance Use During Pregnancy (CDC, 2025)
• Recommended Treatment of Co-Occurring Stimulant Use Disorder and Opioid Use Disorder: Proposed Position of Maine Opioid Response Clinical Advisory Committee (Maine DHHS, 2020)
• Clinical Recommendations on Marijuana Use During Pregnancy and Lactation (SCOG, 2017)
• Research Report on Substance Use While Pregnant and Breastfeeding (NIDA, 2020)
• Fetal Alcohol Spectrum Disorders - Tools and Resources (ACOG)

Screening for Health-Related Social Needs

• MaineMOM CMS Accountable Health Communities’ (AHC) Health-Related Social Needs (HRSN) Screening Tool (MaineCare, 2020)

Stigma Awareness and SUD

• Online Resource on Stigma of Substance Use in Pregnancy (March of Dimes)
• Substance Use in Pregnancy: Identifying Stigma and Improving Care (PDF)
• Words Matter - Terms to Use and Avoid When Talking About Addiction: Self-study module with CME credits from National Institute on Drug Abuse
• Your Words Matter -- Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by SUD: Self-study module with CME credits from National Institute on Drug Abuse

Substance Exposed Infants

• Plan of Safe Care | CDC Maternal and Child Health | Population Health | Maine DHHS
• Information Webpage on Neonatal Abstinence Syndrome (March of Dimes, 2019)
• Rack Cards on Substance Exposed Infants (Maine Prevention Store, 2020)

Treatment Recommendations for Opioid Use Disorder during Pregnancy

• Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder (Office of MaineCare Services, 2021) (PDF)
• Clinical Guidance for Treating Pregnant and Parenting Individuals with Opioid Use Disorder and their Infants (SAMHSA, 2018)
• FAQ on Substance Use and Pregnancy (ACOG, 2020)

Urine Toxicology Testing 

• Proposed Guidance for Toxicology Testing of Pregnant Patients (Office of MaineCare Services, 2021) (PDF)
• Clinical Drug Testing in Primary Care SAMHSA's Technical Assistance Publication Series 32 (PDF)

 

MaineCare Member Resources

• Breastfeeding and Substance Use: A Parent Resource
• Caregiver and Family Resources | Perinatal Quality Collaborative for Maine

Questions?

Please reach out to MaineMOM@maine.gov